ALUMIS INC. (ALMS) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for ALUMIS INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, ALUMIS INC.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Positive
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does ALUMIS INC. actually do?
Answer:
Alumis Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for immune-mediated diseases, aiming to replace broad immunosuppression with precision treatments. The company's lead candidates are envudeucitinib (envu) and A-005, both TYK2 inhibitors, with envu in Phase 3 trials for plaque psoriasis and Phase 2b for systemic lupus erythematosus, and A-005 in Phase 1 for CNS applications. Alumis also acquired lonigutamab, an IGF-1R monoclonal antibody for Thyroid Eye Disease, through its merger with ACELYRIN. The company leverages a proprietary data analytics platform to guide its precision approach, selecting targets and optimizing drug development for improved patient outcomes.
Question:
What are ALUMIS INC.'s revenue drivers?
Answer:
Revenue is primarily driven by collaboration and license agreements, such as the agreement with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of envu in Japan. Future revenue is expected from the successful commercialization of its product candidates.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required